Professor James Walters
Prosiectau fel Prif Ymchwiliwr
1 o 6
- 3/3 Sequencing and Trans-Diagnostic Phenotyping of Severe Mental Illness in Diverse
Populations (01.09.2022 - 30.06.2028) - Antidepressant for the prevention of DEPression following first episode Psychosis trial (ADEPP) (01.11.2019 - 31.12.2023)
- A Stratified Treatment Algorithm in Psychiatry: A program on stratified pharmacogenomics in severe mental illness (01.10.2022 - 30.09.2027)
- CLEAR: (CLozapine in EARly psychosis) A multi-centre, randomised controlled trial of Clozapine for Young people with treatment resistant psychosis in real world settings (01.09.2021 - 30.04.2025)
- CONNECT: Digital markers to predict psychosis relapse (01.11.2022 - 31.03.2027)
Prosiectau fel Cyd-Ymchwiliwr
1 o 4
- 5/7 Psychiatric genomics consortium: Advancing discovery and impact (06.04.2021 - 28.02.2026)
- Cardiff Online Cognitive Assessment (CONCA): An online tool for clinical monitoring of cognition in patients with psychosis (01.10.2024 - 30.09.2027)
- Defining the disturbance in cortical glutamate and GABA function in psychosis, its origins and consequences (03.02.2014 - 02.08.2018)
- Genetic susceptibility to a deficit in contextual processing across the schizophrenia/bipolar disorder diagnostic divide (01.10.2007 - 30.09.2010)
- Identify new potential cellular targets (pathways, molecules, genes) for therapeutic intervention in schizophrenia (01.10.2018 - 30.04.2023)
Thomson Reuters Deutschland GmbH
Zur Giesserei 2
D-76227 Karlsruhe | Germany